PATIENT INFORMATION LEAFLET
Bilastina Noucor 20 mg tablets EFG
Read this leaflet carefully before starting to take this medicine, as it contains important information for you.
Contents of the leaflet:
Bilastina Noucor contains bilastina as the active ingredient, which is an antihistamine. Bilastina is used to relieve the symptoms of allergic rhinoconjunctivitis (sneezing, nasal itching, nasal discharge, nasal congestion, and red and itchy eyes) and other forms of allergic rhinitis. It may also be used to treat itchy skin eruptions (hives or urticaria).
Do not take Bilastina Noucor:
If you are allergic to bilastina or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to use Bilastina Noucor if you have moderate or severe kidney impairment, low blood potassium, magnesium, or calcium levels, if you have or have had heart rhythm problems or if your heart rate is very low, if you are taking medicines that may affect your heart rhythm, if you have or have had a certain abnormal heart rhythm pattern (known as QTc interval prolongation on the electrocardiogram) that may occur in some types of heart diseases and are also taking other medicines (see "Using Bilastina Noucor with other medicines").
Children
Do not give this medicine to children under 12 years of age.
Do notexceed the recommended dose. If symptoms persist, consult your doctor.
Using Bilastina Noucor with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription.
In particular, please inform your doctor if you are taking any of the following medicines:
Taking Bilastina Noucor with food, drinks, and alcohol
These tablets must notbe taken with foodor with grapefruit juice or other fruit juices, as this would reduce the effect of bilastina. To avoid this, you can:
Bilastina, at the recommended dose (20 mg), does not increase the drowsiness caused by alcohol.
Pregnancy, breastfeeding, and fertility
There are no data or limited data on the use of bilastina in pregnant women, during breastfeeding, or on fertility.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
It has been shown that bilastina 20 mg does not affect performance during driving in adults. However, each patient's response to the medicine may be different. Therefore, check how this medicine affects you before driving or using machines.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose in adults, including elderly patients and adolescents 12 years of age and older, is 1 tablet (20 mg) per day.
Regarding the duration of treatment, your doctor will determine the type of disease you have and tell you how long you should take bilastina.
Use in children
For children 6 to 11 years of age with a minimum body weight of 20 kg, other pharmaceutical forms are more suitable - bilastina 10 mg orodispersible tablets or bilastina 2.5 mg/mL oral solution. Consult your doctor or pharmacist.
Do not give this medicine to children under 6 years of age with a body weight below 20 kg, as there are not enough data available.
If you take more Bilastina Noucor than you should
If you or anyone else takes more of this medicine than they should, tell your doctor immediately or go to the nearest hospital emergency department. Please remember to take this medicine package or this leaflet with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20 (indicating the medicine and the amount ingested).
If you forget to take Bilastina Noucor
Do nottake a double dose to make up for a forgotten dose.
If you forget to take your dose, take it as soon as possible, and then return to your usual dosing schedule.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects that may occur in adults and adolescents are:
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Frequency not known: cannot be estimated from the available data
Side effects that may occur in children:
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the package and blister. The expiry date is the last day of the month stated.
This medicine does not require special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for proper disposal. If you are unsure, ask your pharmacist how to dispose of unused medicines and packaging. This will help protect the environment.
Composition of Bilastina Noucor:
Appearance and packaging of the product:
Bilastina Noucor are white, round tablets, 7 mm in diameter.
The tablets are packaged in blisters of 20 or 30 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder:
Noucor Health, S.A.
Avinguda Camí Reial 51-57,
Poligono Industrial Riera de Caldes
08184, Palau-solità i Plegamans (Barcelona),
Spain
Manufacturer
Noucor Health, S.A.
Avinguda Camí Reial 51-57,
Poligono Industrial Riera de Caldes
08184, Palau-solità i Plegamans (Barcelona),
Spain
Date of last revision of this leaflet: February 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/